Filing Details

Accession Number:
0000899243-20-022418
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-14 16:37:04
Reporting Period:
2020-08-12
Accepted Time:
2020-08-14 16:37:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1490978 Schrodinger Inc. SDGR Pharmaceutical Preparations (2834) 954284541
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1797707 Ramy Farid C/o Schrodinger, Inc.,
120 West 45Th Street, 17Th Floor
New York NY 10036
See Remarks Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-08-12 1,000 $64.87 333,432 No 4 S Direct
Common Stock Disposition 2020-08-12 3,431 $66.01 330,001 No 4 S Direct
Common Stock Disposition 2020-08-12 34,416 $66.92 295,585 No 4 S Direct
Common Stock Disposition 2020-08-12 36,203 $67.72 259,382 No 4 S Direct
Common Stock Disposition 2020-08-12 4,950 $68.54 254,432 No 4 S Direct
Common Stock Disposition 2020-08-13 18,804 $69.83 235,628 No 4 S Direct
Common Stock Disposition 2020-08-13 15,767 $70.62 219,861 No 4 S Direct
Common Stock Disposition 2020-08-13 15,429 $71.49 204,432 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2020.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.36 to $65.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (9) of this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.37 to $66.35, inclusive.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.38 to $67.37, inclusive.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.38 to $68.35, inclusive.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.38 to $68.78, inclusive.
  7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.25 to $70.235, inclusive.
  8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.26 to $71.19, inclusive.
  9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.29 to $71.98, inclusive.